Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling
2020 · Annals of the Rheumatic Diseases · 27 citations
https://doi.org/10.1136/annrheumdis-2019-216847
M
Miriam Bollmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
454
Citations
9
h-index
9
i10-index
Miriam Bollmann is an academic researcher from National Academy of Medicine. The author has contributed to research in topics: Osteoarthritis Treatment and Mechanisms & Protease and Inhibitor Mechanisms & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 9, co-authored 25 publications.
ORCID: 0000-0003-1639-8079Papers by this author
worksDelineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes
2019 · BMC Genomics · 12 citations
https://doi.org/10.1186/s12864-019-5539-y
Combination treatment with anti-RANKL and antibiotics for preventing joint destruction in septic arthritis
2025 · JCI Insight · 2 citations
https://doi.org/10.1172/jci.insight.184954
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat